skip to content

Cambridge Academy of Therapeutic Sciences

Cambridge Academy of Therapeutic Sciences opens for business

21 March 2017

On 9 March, Vice Chancellor Professor Sir Leszek Borysiewicz and Pro-Vice Chancellor for Research, Professor Chris Abell welcomed an audience of 150 pharmaceutical and biotech company leaders, industry and professional body representatives, and senior academics to hear about the mission and vision of the Cambridge Academy...

Read more

Entrepreneurs in Residence

Our Entrepreneurs in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with Cambridge...

Read more

Development of optoacoustic imaging for breast cancer detection advanced by collaboration with Munich-based small company

In 2015, Professor Fiona Gilbert, Honorary Consultant Radiologist with Addenbrooke’s Hospital and Professor of Radiology at Cambridge University's School of Clinical Medicine, successfully applied for a grant from our Research Exchange scheme to carry out collaborative work with iThera Medical, a Munich-based spin out...

Read more

Digi‐Vis: an all‐in‐one digital visual function assessment system

Dr Louise Allen is a Consultant Ophthalmic Surgeon based at Addenbrooke’s Hospital and an Associate Lecturer at the University of Cambridge. After meeting with Entrepreneur-in-Residence, John Pritchard, Louise successfully applied for funding from Cambridge University Health Partners (CUHP) and from the MRC Confidence-in-...

Read more

Latest news

Apollo's mission to drive therapeutic innovation

21 June 2017

The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines – faster and with fewer failures – and it’s being led by three UK universities and three global pharmaceutical companies. In January 2016, the tech transfer offices (TTOs) of...

Patching up a broken heart

21 June 2017

It is almost impossible for an injured heart to fully mend itself. Within minutes of being deprived of oxygen – as happens during a heart attack when arteries to the heart are blocked – the heart’s muscle cells start to die. Dr Sanjay Sinah leads a team of stem cell biologists in the Cambridge Stem Cell Institute. Over the...

Cambridge start-up raises £40 million in funding to develop new cancer treatments

21 June 2017

Cambridge-based start-up Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials. The company is developing a new class of drugs called ‘Bicycles’, which are based on small protein chains, or peptides, which have been chemically constrained, and...